The notices it replaced
- Reissues: PAR-21-341 Exploratory Grants in Cancer Control (R21 Clinical Trial Optional)
- 2 steps back: PAR-19-277 Exploratory Grants in Cancer Epidemiology (R21 Clinical Trial Optional)
- 3 steps back: PA-16-175 Exploratory Grants in Cancer Epidemiology and Genomics Research (R21)
Who won it before
41 competing awards (new and renewals) from FY2014 to FY2025 under this notice and the notices it replaced: $11,848,459 in first-year total cost, median $245,120.
Most frequent study sections
- Cancer, Heart, and Sleep Epidemiology B Study Section[CHSB]6
- Cancer, Heart, and Sleep Epidemiology A Study Section[CHSA]5
- Biobehavioral Medicine and Health Outcomes Study Section[BMHO]3
- Cancer and Hematologic Disorders Study Section[CHD]3
- Chemo/Dietary Prevention Study Section[CDP]3
Most frequent institutions
- ARIZONA STATE UNIVERSITY-TEMPE CAMPUS2
- CEDARS-SINAI MEDICAL CENTER2
- HARVARD SCHOOL OF PUBLIC HEALTH2
- MASSACHUSETTS GENERAL HOSPITAL2
- MAYO CLINIC ROCHESTER2
| FY | Project | PIs | Institution | First-year cost | Study section |
|---|---|---|---|---|---|
| 2025 | Using targeted and non-targeted approaches to examine per- and polyfluoroalkyl substances (PFAS) exposure and glioma risk in young children1R21CA293549-01A1 · under PAR-21-341 | MA, XIAOMEIPOLLITT, KRYSTAL | YALE UNIVERSITY, CT | $431,377 | ZRG1 |
| 2025 | Recalibrating the Lung Cancer Policy Model to Address Lung Cancer Risk and Lung Cancer Screening Practices in Real-World Populations1R21CA301039-01 · under PAR-21-341 | YANG, CHI-FU | MASSACHUSETTS GENERAL HOSPITAL, MA | $429,399 | ODHS |
| 2025 | Generalized and Cancer-Related Episodic Future Thinking for Smoking Cessation: Proof-of-Concept and Feasibility Testing1R21CA294049-01A1 · under PAR-21-341 | STEIN, JEFFREY SCOTT | VIRGINIA POLYTECHNIC INST AND ST UNIV, VA | $395,248 | IPTA |
| 2025 | Epigenetics, accelerated aging, and cardiovascular health during breast cancer treatment1R21CA300956-01 · under PAR-21-341 | VASBINDER, ALEXI L | UNIVERSITY OF WASHINGTON, WA | $279,411 | CCHS |
| 2025 | BReaTHS: Breast cancer Radiation Training for improved Heart Safety1R21CA300943-01 · under PAR-21-341 | SALWEI, MEGAN ELIZABETH | VANDERBILT UNIVERSITY MEDICAL CENTER, TN | $246,124 | ZRG1 |
| 2025 | Developing AI-measures of Pedestrian Environment Features for Physical Activity and Cancer Prevention in Rural Communities1R21CA293976-01A1 · under PAR-21-341 | ADAMS, MARC AWENDE, MARILYN ELIZABETH | ARIZONA STATE UNIVERSITY-TEMPE CAMPUS, AZ | $231,710 | CIHB |
| 2025 | Cancer Care Companion: An Electronic Health Record Tool to Improve Information Exchange and Self-Management in Pediatric Cancer1R21CA290223-01A1 · under PAR-21-341 | SISK, BRYAN ANTHONY | WASHINGTON UNIVERSITY, MO | $227,941 | ICSC |
| 2024 | A Blended e-Health Intervention for Fear of Progression in Advanced GYN Cancer1R21CA293326-01 · under PAR-21-341 | REB, ANNE | BECKMAN RESEARCH INSTITUTE/CITY OF HOPE, CA | $489,500 | CMGC |
| 2024 | Assessment of consumer response to smokeless tobacco modified risk marketing orders1R21CA289541-01 · under PAR-21-341 | O'CONNOR, RICHARD JWACKOWSKI, OLIVIA | ROSWELL PARK CANCER INSTITUTE CORP, NY | $443,509 | LHB |
| 2024 | Epidemiologic study of microplastic pollution in bronchoalveolar lavage fluid and its association with lung cancer1R21CA293440-01 · under PAR-21-341 | EGAN, KATHLEEN M. | H. LEE MOFFITT CANCER CTR & RES INST, FL | $425,772 | CHD |
| 2024 | Role of the inflammatory dietary pattern in gut and colon tissue microbiomes and impact on survival outcomes among colorectal cancer patients1R21CA294050-01 · under PAR-21-341 | TABUNG, FRED KINYUY | OHIO STATE UNIVERSITY, OH | $405,316 | CHD |
| 2024 | The Role of Early Life Exposure to Antibiotics on Risk of Early Onset Colorectal Cancer1R21CA281729-01A1 · under PAR-21-341 | PENA, MARIA MARJORETTE | UNIVERSITY OF SOUTH CAROLINA AT COLUMBIA, SC | $372,142 | CPSS |
| 2024 | Identifying and Addressing Barriers in the Cervical Cancer Treatment Cascade among Women with HIV in South Africa1R21CA279942-01A1 · under PAR-21-341 | PSAROS, CHRISTINASTANTON, AMELIA M. | BOSTON UNIVERSITY (CHARLES RIVER CAMPUS), MA | $368,070 | PPAH |
| 2024 | Sexual Health and Rehabilitation (SHARE): An Online Educational Intervention for Young Adult Female Cancer Survivors1R21CA279278-01A1 · under PAR-21-341 | BOBER, SHARON L. | DANA-FARBER CANCER INST, MA | $255,280 | BMHO |
| 2024 | Caregiver Education with Interactive Neurodevelopmental Games to Improve Cognitive and Social-Emotional Outcomes in Infants Undergoing Treatment for Medulloblastoma1R21CA280187-01A1 · under PAR-21-341 | CONKLIN, HEATHER M | ST. JUDE CHILDREN'S RESEARCH HOSPITAL, TN | $251,912 | PDRP |
| 2024 | Clonal growth and prediction of monoclonal B-cell lymphocytosis1R21CA282702-01A1 · under PAR-21-341 | GRIFFIN, ROSALIESEKAR, ASWIN | MAYO CLINIC ROCHESTER, MN | $245,120 | CHD |
| 2024 | Understanding patient-surgeon interactions to support deimplementation of preference-sensitive low value care1R21CA283601-01A1 · under PAR-21-341 | NEUMAN, HEATHER B | UNIVERSITY OF WISCONSIN-MADISON, WI | $194,714 | SIHH |
| 2024 | Innovating CBT-I for Cancer Survivors: An Optimization Trial1R21CA279248-01A1 · under PAR-21-341 | HALL, DANIEL LEE | MASSACHUSETTS GENERAL HOSPITAL, MA | $187,935 | BMHO |
| 2023 | Mates in Motion: Feasibility and Acceptability of a Couple-Based Physical Activity Intervention1R21CA275085-01A1 · under PAR-21-341 | LANGER, SHELBY | ARIZONA STATE UNIVERSITY-TEMPE CAMPUS, AZ | $419,253 | LCBH |
| 2023 | The Feasibility and Acceptability of Resistance Training and Creatine Supplementation to Promote Physical Function in Sarcopenic Colorectal Cancer Survivors1R21CA281951-01 · under PAR-21-341 | FAIRMAN, CIARAN | UNIVERSITY OF SOUTH CAROLINA AT COLUMBIA, SC | $202,696 | BMHO |
| 2022 | Leveraging Medicare Linkages to Identify New Associations: Prescription Drugs and Digestive Cancer Risk1R21CA263489-01A1 · under PAR-19-277 | BYKOV, KATSIARYNADU, MENGMENGKANTOR, ELIZABETH DAVID | SLOAN-KETTERING INST CAN RESEARCH, NY | $488,048 | CHSB |
| 2022 | Breast cancer neoadjuvant endocrine therapy during the Covid-19 pandemic: Opportunity for a new treatment paradigm?1R21CA270625-01 · under PAR-19-277 | NYANTE, SARAH JANE | UNIV OF NORTH CAROLINA CHAPEL HILL, NC | $181,741 | CBSS |
| 2021 | Inflammatory oxylipins and aromatase inhibitor toxicity in breast cancer1R21CA251343-01A1 · under PAR-19-277 | HENRY, NORAH LYNN | UNIVERSITY OF MICHIGAN AT ANN ARBOR, MI | $427,833 | CHSB |
| 2021 | Informing Cancer Epidemiology Through the Identification of Differentiating Chemical Constituents of Cigarillo Smoke1R21CA263809-01 · under PAR-19-277 | KLUPINSKI, THEODORE P. | BATTELLE CENTERS/PUB HLTH RES & EVALUATN, OH | $409,936 | SIEE |
| 2020 | Metabolomic and miRNA profiling of vitreous humor in uveal melanoma1R21CA241840-01A1 · under PAR-19-277 | DEMIRCI, F. YESIM | UNIVERSITY OF PITTSBURGH AT PITTSBURGH, PA | $415,342 | CBSS |
| 2020 | Modeling multiple environmental exposures and childhood leukemia risk1R21CA238370-01A1 · under PA-16-175 | WHEELER, DAVID CHARLES | VIRGINIA COMMONWEALTH UNIVERSITY, VA | $226,490 | CHSB |
| 2019 | Circulating Antibodies to Oral Microbiota and Colon Cancer Risk1R21CA234436-01 · under PA-16-175 | MICHAUD, DOMINIQUE S. | TUFTS UNIVERSITY BOSTON, MA | $250,540 | CHSB |
| 2019 | Computational Identification of new candidate drugs for lung cancer treatment1R21CA227996-01A1 · under PA-16-175 | CHENG, CHAOONEGA, TRACY | BAYLOR COLLEGE OF MEDICINE, TX | $222,863 | BCHI |
| 2019 | Profiling DNA adducts in formalin fixed paraffin embedded human colorectal tissue1R21CA235094-01A1 · under PA-16-175 | TURESKY, ROBERT J. | UNIVERSITY OF MINNESOTA, MN | $212,715 | CPSS |
| 2019 | Genetic Epidemiology of Breast Cancer Disparities in Women of African Ancestry1UH2CA227608-01A1 · under PA-16-175 | OCHS-BALCOM, HEATHER M | STATE UNIVERSITY OF NEW YORK AT BUFFALO, NY | $192,184 | CHSB |
| 2019 | Improving confounder control in EHR-based studies of cancer epidemiology1R21CA227613-01A1 · under PA-16-175 | HUBBARD, REBECCA | UNIVERSITY OF PENNSYLVANIA, PA | $186,664 | CHSA |
| 2019 | Development of an automated method to capture bladder cancer recurrence and progression for epidemiologic research1R21CA227606-01A1 · under PA-16-175 | DANFORTH, KIM NKAWATKAR, ANIKET A | KAISER FOUNDATION RESEARCH INSTITUTE, CA | $172,270 | CHSA |
| 2018 | Integrating diet, lifestyle and tumor tissue molecular subtyping to study the role of adolescent calcium intake on the risk of early onset colorectal neoplasia1R21CA230873-01 · under PA-16-175 | OGINO, SHUJIWU, KANA | HARVARD SCHOOL OF PUBLIC HEALTH, MA | $246,987 | CDP |
| 2018 | Integrating diet and tissue whole exome sequencing data to study processed meat and colorectal cancer1R21CA222940-01 · under PA-16-175 | NISHIHARA, REIKOWU, KANA | HARVARD SCHOOL OF PUBLIC HEALTH, MA | $243,471 | CDP |
| 2018 | Estimation and association analysis of biomarkers for tumor immune microenvironment1R21CA224026-01 · under PA-16-175 | SUN, WEI | FRED HUTCHINSON CANCER RESEARCH CENTER, WA | $229,680 | BMRD |
| 2018 | T cell responses shared among triple negative breast cancer patients1R21CA230487-01 · under PA-16-175 | SLANSKY, JILL E | UNIVERSITY OF COLORADO DENVER, CO | $209,895 | CII |
| 2018 | Epidemiology and Genomics of Ovarian Clear Cell Carcinoma1R21CA222867-01A1 · under PA-16-175 | GOODE, ELLEN L. | MAYO CLINIC ROCHESTER, MN | $207,495 | CHSA |
| 2018 | Predicting the diagnosis of pancreatic cancer by leveraging big data1R21CA220073-01A1 · under PA-16-175 | JEON, CHRISTIE YOUNGHAE | CEDARS-SINAI MEDICAL CENTER, CA | $203,197 | CHSB |
| 2018 | Improving Breast Cancer Risk Prediction with Composite Measures of Obesity and Body Fat Distribution1R21CA220080-01A1 · under PA-16-175 | SHVETSOV, YURII B | UNIVERSITY OF HAWAII AT MANOA, HI | $200,970 | CHSA |
| 2018 | Understanding sex differences in colon cancer metabolism1R21CA223686-01A1 · under PA-16-175 | JOHNSON, CAROLINE HELENKHAN, SAJID A | YALE UNIVERSITY, CT | $182,156 | CDP |
| 2017 | The Role of Splice Quantitative Traits in Ovarian Cancer Pathogenesis1R21CA220078-01 · under PA-16-175 | LAWRENSON, KATEPASANIUC, BOGDAN | CEDARS-SINAI MEDICAL CENTER, CA | $235,553 | CHSA |
Data: Grants.gov's daily extract and NIH's notice pages and award files, in ScienceGraph release conductgrants-2026-11-09-0.1.0. An award is listed only where NIH's own record names the notice, and a PI only by NIH's profile ID. Grants.gov and NIH do not endorse ScienceDex.